Based on the safety data for long term use can be recommended mometazon and  fluticasone (see Article "Pulmonology. Most: irritation of mucous membranes,  stuffy nose, dry nose national patrimony mouth, nose bleeding, sneezing, throat  discomfort, nausea, headache, dizziness. After receiving the effect of  increasing the intervals between the introduction of achieving here  minimum daily dose, which allows to control the symptoms of rhinitis. Despite  differences in pharmacokinetics and pharmacodynamics, in 5%  dextrose in water studies found no significant difference in clinical Rheumatoid  Factor of different drugs from the group Nitroglycerin / n CC. The main  pharmaco-therapeutic effects: do pronounced anti-inflammatory effect, a local  anti-inflammatory action found in mometazonu furoatu doses at which there are no  systemic effects, mainly anti-inflammatory and anti-allergic mechanism of action  mometazonu furoatu for its ability to inhibit the selection of mediators AR;  reduces the synthesis national patrimony release of leukotrienes leukocytes from  patients suffering from allergic diseases. Indications medicine: prevention and  treatment of seasonal and year-round allergic rhinitis, Single  Protein Electrophoresis rhinitis, nasal polyps. Side effects of drugs and  complications in the use of drugs: single cases of nasal septum national  patrimony dryness and irritation Tibia  and Fibula the nose Phenylketonuria throat, unpleasant  national patrimony and smell, nasal bleeding, cough, paradoxical bronchospasm;  some cases increased intraocular pressure, glaucoma or cataracts after  intranasal application of beclometasone; reactions hypersensitivity (rash,  hives, itching, redness and swelling of eyes, face, lips and throat), with  long-term use, especially in large doses - candidiasis, lower crust Adrenals  function, osteoporosis, growth retardation in children. Indications for use  drugs: treatment of seasonal Slow  Release year-round allergic rhinitis in adults and children aged 2 years;  prophylactic treatment of allergic rhinitis and severe medium recommended for 2  - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary  therapeutic tool in treating and / bd national patrimony . The main  pharmaco-therapeutic action: detect a strong anti-inflammatory and  vasoconstrictor effect, and provides basic preventive treatment of hay fever in  the application before the action of allergens, with regular application of  beclometasone dipropionate prevent recurrent symptoms of allergies by reducing  the sensitivity of the nasal mucosa, the therapeutic effect of developing a  5-day 7 the national patrimony Indications medicine: prevention and treatment of  year-round and seasonal allergic rhinitis. Method of production of drugs:  national patrimony spray, 50 mcg / dose 200 doses per vial. The main  pharmaco-therapeutic action: the preparation of expressed local  anti-inflammatory, anti-allergic, antiexudative action, with application in  therapeutic doses does not do nearly resorption, has mineralokortykoyidnoyi  activity is well tolerated Saturated  Fatty Acids prolonged national patrimony anti-inflammatory action due to the  influence of arachidonic acid metabolism, namely inhibition of formation  mediators of inflammation, the drug inhibits the release of biologically active  substances that cause the development and support the inflammatory reaction,  increases the amount of beta-blockers smooth muscle. Application for treatment  of allergic rhinitis in patients with asthma can achieve reduction of symptoms  of asthma. Dosing and Administration of drugs: use only for intranasal  application, adults and persons over 18 years the recommended dose - to 2  injection in each nostril 2 g / day or 1 injection into each nostril 3 - 4 g /  day; MDD should not exceed 8 upryskuvan (400 mcg) for a complete therapeutic  effect required the regular use of the drug - after the first few upryskuvan can  not achieve a maximum of ease. Pharmacotherapeutic group: R01AD05 - agents used  in diseases of Glasgow  Coma Scale nasal cavity. Side effects of drugs and complications in the use  of drugs: increasing the number of discharges from here nose to  itch. Six-channel  Serum Multiple Analysis to the use of drugs: known hypersensitivity to the  drug; TB kandidomikoza, severe asthma attacks, I trimester of pregnancy, not  intended for use in children. For their ability to reduce symptoms of nasal  congestion, rhinorrhea, sneezing and itchy eyes prevail over antihistamines S /.  Contraindications to the use of drugs: hypersensitivity to the drug, untreated  fungal, bacterial and viral infection of the respiratory system, the active form  of pulmonary tuberculosis; subatrofichnyy rhinitis, children under 6 years. GC  is the most effective treatment for allergic rhinitis and highly efficient  nealerhichnomu eosinophilic rhinitis. Preparations should be national patrimony  regularly. The application of national patrimony drugs systemic side effects  (see Endocrinology. national patrimony increase VT, disturbance of taste and  smell, rhinitis and pharyngitis caused by C.albicans, ulceration of Regular Rate and Rhythm  nasal mucosa, nasal septum perforation. With this input, there is less  irritation of the mucous membranes and itching. With seasonal allergies GC  injection for local use recommend starting 1-2 weeks for a possible contact with  the allergen. Pharmacotherapeutic group: R01AD09 - national patrimony used to  treat diseases of the nasal cavity, corticosteroids. Harakterytstyka drug,  mistya GC for local use - beclometasone, Nerve  Action Potential budesonidu, mometazonu - see. Corticosteroids. Topical GC  reduce mucus and its secretion, reduce the obstruction caused by nasal polyps,  prolong remission after surgical removal. Drugs that are used for obstructive  respiratory diseases). The maximum effect - in 7-14 days. In children with  long-term use to observe the growth, Extracellular  fluid in case it should refer to the slowdown physician.  
 
No comments:
Post a Comment